| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = -$10,976 ) |
| | 2022 | 2021 | VULCAN BIOLOGICS INC | 27 ANGELOU ST | IRVINE | CA | 92617-4064 | ORANGE | USA | R43DE030028 | Combining Bacteriophage-Mediated Decolonization with Microbial Engraftment to Foster Sustained Supragingival Microbiome Modulation for Enhanced Anti-Cariogenic Therapy | 000 | 1 | NIH | 11/20/2021 | -$10,976 |
|
| Issue Date FY: 2021 ( Subtotal = $10,976 ) |
| | 2021 | 2021 | VULCAN BIOLOGICS, INC. | 27 ANGELOU ST | IRVINE | CA | 92617-4064 | ORANGE | USA | R43DE030028 | Combining Bacteriophage-Mediated Decolonization with Microbial Engraftment to Foster Sustained Supragingival Microbiome Modulation for Enhanced Anti-Cariogenic Therapy | 001 | 1 | NIH | 4/13/2021 | $10,976 |
| | 2021 | 2021 | VULCAN BIOLOGICS, INC. | 27 ANGELOU ST | IRVINE | CA | 92617-4064 | ORANGE | USA | R43DE030028 | Combining Bacteriophage-Mediated Decolonization with Microbial Engraftment to Foster Sustained Supragingival Microbiome Modulation for Enhanced Anti-Cariogenic Therapy | 000 | 1 | NIH | 1/14/2021 | $10,976 |
| | 2021 | 2021 | VULCAN BIOLOGICS, INC. | 27 ANGELOU ST | IRVINE | CA | 92617-4064 | ORANGE | USA | R43DE030028 | Combining Bacteriophage-Mediated Decolonization with Microbial Engraftment to Foster Sustained Supragingival Microbiome Modulation for Enhanced Anti-Cariogenic Therapy | 001 | 1 | NIH | 4/13/2021 | -$10,976 |
|
| Issue Date FY: 2020 ( Subtotal = $256,580 ) |
| | 2020 | 2020 | VULCAN BIOLOGICS, INC. | 27 ANGELOU ST | IRVINE | CA | 92617-4064 | ORANGE | USA | R43DE030028 | Combining Bacteriophage-Mediated Decolonization with Microbial Engraftment to Foster Sustained Supragingival Microbiome Modulation for Enhanced Anti-Cariogenic Therapy | 000 | 1 | NIH | 9/16/2020 | $256,580 |
|
|
